Evaluating pharmaceutical R\&D under technical and economic uncertainty

From MaRDI portal
Publication:421539

DOI10.1016/j.ejor.2011.01.055zbMath1237.90148OpenAlexW2029037539MaRDI QIDQ421539

Luigi Sereno, Enrico Pennings

Publication date: 14 May 2012

Published in: European Journal of Operational Research (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1016/j.ejor.2011.01.055




Related Items (25)

Investment timing and capacity choice in duopolistic competition under a jump-diffusion modelN-Fold compound option pricing with technical risk under fractional jump-diffusion modelA geometric Lévy model for \(n\)-fold compound option pricing in a fuzzy frameworkVenture capital, staged financing and optimal funding policies under uncertaintyStaged venture capital investment considering unexpected major eventsEuropean option based R\&D investment decision making under uncertaintiesA simple method for generalized sequential compound options pricingPatent valuation under spatial point processes with delayed and decreasing jump intensityValuing portfolios of interdependent real options under exogenous and endogenous uncertaintiesMulti-stage real option evaluation with double barrier under stochastic volatility and interest rateValuation of \(N\)-stage investments under jump-diffusion processesStatistical properties and economic implications of jump-diffusion processes with shot-noise effectsQuasi-analytical solution of an investment problem with decreasing investment cost due to technological innovationsAnalytical solution for an investment problem under uncertainties with shocksA real options game of alliance timing decisions in biopharmaceutical research and developmentA stochastic model with interacting managerial operating options and debt reschedulingReal options in operations research: a reviewRisky choices in strategic environments: an experimental investigation of a real options gameA real options based decision support tool for R\&D investment: application to CO\(_2\) recycling technologyValuing multistage investment projects in the pharmaceutical industryA model of investment under uncertainty with time to build, market incompleteness and risk aversionOptimal product release time for a new high-tech startup firm under technical uncertaintyOptimal investment in research and development under uncertaintyTo expand and to abandon: real options under asset variance risk premiumStochastic competitive entries and dynamic pricing



Cites Work


This page was built for publication: Evaluating pharmaceutical R\&D under technical and economic uncertainty